Merck MRK

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
    1. Incyte 2Q Results as Expected; Despite Pipeline Progress Shares Remain Fully Valued

      Commentary

      Thu, 31 Jul 2014

      s PD-L1 immune checkpoint inhibitor MPDL3280A in lung cancer patients. This follows similar deals with AstraZeneca, Merck , and Bristol-Myers Squibb, which are all focused on the potential for synergistic effects with other immuno-oncology

    2. New Morningstar Analyst Report for Regeneron Pharmaceuticals Inc

      Stock Reports

      Wed, 30 Jul 2014

      1988. The company’s board is led by P. Roy Vagelos, who has served as chairman since 1995 and is the former CEO of Merck , and includes several seasoned biotech and pharma executives and scientific luminaries, notably three Nobel Prize winners

    3. Bayer Posts Steady Second Quarter as Recently Launched Drugs Offset Declines From Mature Drugs

      Commentary

      Wed, 30 Jul 2014

      no-moat material science group weighs down overall returns for the company. However, the recently announced acquisition of Merck 's consumer health group should help dilute the negative pressure from the material science segment. In the quarter

    4. Cramer's Mad Money - The Pause That Depresses (7/29/14)

      Headlines

      Wed, 30 Jul 2014

      Communications (NASDAQ: FTR ), Gilead (NASDAQ: GILD ), Merck (NYSE: MRK ), Amgen (NASDAQ: AMGN ), Twitter (NYSE: TWTR ..... performing well, including good news from Gilead ( GILD ), Merck ( MRK ) and Amgen (AGMN). Some areas of tech are strong

    5. US STOCKS-Wall Street ends down; Twitter rallies after-hours

      Headlines

      Tue, 29 Jul 2014

      * Merck up as results beat expectations, but Pfizer slips

    6. Merck's ( MRK ) CEO Ken Frazier On Q2 2014 Results - Earnings Call Transcript

      Headlines

      Tue, 29 Jul 2014

      Merck & Co., Inc. (NYSE: MRK ) Q2 2014 Earnings Conference Call July ..... Human Health Roger Perlmutter - Head of Merck Research Labs Analysts John Boris ..... Operator Good day everyone, and welcome to Merck ’s Second Quarter 2014 Earnings Conference

    7. Merck quarterly profit beats estimates; shares gain

      Headlines

      Tue, 29 Jul 2014

      (Reuters) - Merck & Co Inc reported better-than-expected quarterly results on Tuesday, helped by strong sales of consumer products and medicines for arthritis and HIV, sending its shares up more than 1 percent in morning trading.

    8. UPDATE 3- Merck quarterly profit beats estimates; shares gain

      Headlines

      Tue, 29 Jul 2014

      (Adds comments from CEO, analysts, details on drug pipeline)

    9. BRIEF- Merck says not interested in doing deals solely or primarily for tax inversions

      Headlines

      Tue, 29 Jul 2014

      July 29 (Reuters) - Merck & Co Inc : * CEO in investor conference call says company not interested in doing deals solely or primarily because of

    10. Stock futures point higher ahead of FOMC meeting, boosted by earnings

      Headlines

      Tue, 29 Jul 2014

      optimistic on China following improving economic data such as HSBC's July factory activity report. Dow-listed pharmas Merck and Pfizer posted earnings that easily beat Wall Street estimates, but UPS -2.6% after its quarterly profit fell sharply

    « Prev12345Next »
    Content Partners